LHX2 and adenocarcinoma: The mRNA expression of LHX2 was greatly increased in BRCA, ACC, bladder urothelial carcinoma (BLCA), cervical squamous cell carcinoma and adenocarcinoma (CESC), and most other tumors, despite the opposite results appearing in a few types of tumors (Figure 1A).